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Abstract
The activation of the hypothalamic-pituitary-adrenal (HPA) axis during
inflammation is mediated by prostaglandin E2 (PGE2) produced in the brain. However,
how PGE2 recruits neuronal mechanisms for HPA axis activation remains unknown.
Accumulating evidence indicates that GABA-mediated inhibitory synaptic transmission
plays a major role in the HPA axis regulation. That is, GABAergic transmission
constitutively constrains the excitability of parvocellular neuroendocrine cells (PNCs) in
the paraventricular nucleus of the hypothalamus (the HPA axis output neurons); the
removal from this inhibition (i.e. disinhibition) powerfully activates the HPA axis. My
thesis examined the actions of PGE2 on GABAergic synaptic transmission to PNCs. Using
patch clamp electrophysiology in rats hypothalamic slices, I found that PGE2 dosedependently attenuated GABAergic transmission onto PNCs. The analysis of synaptic
property changes revealed that PGE2 decreased the release of GABA from the presynaptic
terminals whereas it had little, if any, effects on the postsynaptic ionotropic GABA
receptors. By using pharmacological approaches, I also identified that the EP3 subtype of
the PGE2 receptor mediated the actions of PGE2 on GABA synapses. Finally, because
psychological stress is known to influence inflammation-induced HPA axis activation, I
examined the effects of psychological stress on PGE2-induced GABA synapse plasticity.
I found that restraint stress impaired PGE2-induced suppression of GABA release.
Interestingly, however, this modulation by psychological stress was independent of EP3.
In summary, my thesis provides a plausible mechanism for how PGE2 activates the HPA
axis during inflammation, and a potential mechanism for its modulation by psychological
stress.
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1  

Introduction

1.1   The stress response
The survival of organisms depends on maintaining a complex dynamic equilibrium
termed homeostasis (Chrousos, 2009). Any threats to homeostasis, either anticipated or
real, triggers a set of psychological and physiological changes – commonly called stress
response – to manage the impending challenges (Johnson et al., 1992; Bains et al., 2015).
The stress response involves multifaceted changes in both the central nervous
system (CNS) and multiple peripheral organs. The changes in the CNS include enhanced
alertness and cognition as well as suppression of some of the vegetative functions including
appetite, sleep, and reproductive drive. The changes in peripheral functions include
increased heart rate, respiratory rate, blood pressure, and metabolism (Griffin, 1990; Smith
and Vale, 2006; Chrousos, 2009). While these psychophysiological changes associated
with the stress response are primarily adaptive and promote survival, it is well documented
that the stress response can have detrimental consequences when it is excessive and/or in
vulnerable subjects. For example, acute stress can trigger panic attacks, psychotic episodes,
and allergic reactions such as asthma and eczema. Moreover, chronic stress is a strong risk
factor for serious disorders including clinical depression, cognitive impairments, and
metabolic syndrome such as type 2 diabetes mellitus, obesity, and hypertension (Johnson
et al., 1992; Elenkov and Chrousos, 1999; Chrousos, 2009). Thus, it is important to
understand how the stress response promotes survival and how deviation from this adaptive
response may result in detrimental consequences. The focus of this thesis is on the neural
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mechanisms that regulate the hypothalamic-pituitary-adrenal (HPA) axis, the
neuroendocrine hallmark of the stress response.

1.2   The HPA axis
The HPA axis consists of a hormonal cascade starting from the paraventricular
nucleus of the hypothalamus (PVN), and then the anterior lobe of the pituitary gland, and
ultimately the adrenal gland (Figure 1-1). The activation of the HPA axis is initiated by a
population of neuroendocrine neurons in the PVN that synthesize corticotropin-releasing
factor (CRF). The cell bodies of these neurons are primarily clustered in a particular
subdivision of the PVN (the medial parvocellular subdivision) from which they send
projections to the median eminence. The axonal projections terminate onto the
hypophyseal portal vessels which lack the blood-brain-barrier; this allows the CRF released
from the axon terminals to reach the anterior pituitary via the portal circulation. Upon
activation of CRF type 1 receptors (CRFR1), the anterior pituitary lobe releases
adrenocorticotropic hormone (ACTH) into the systemic blood stream. Consequently,
ACTH reaches the adrenal grand, binds to melanocortin type 2 receptors (MC2-R) in the
adrenal cortex and stimulates the synthesis and release of the glucocorticoids (GCs) from
the zona fasciculata (Smith and Vale, 2006; Herman et al., 2016). GCs, the ultimate output
of the HPA axis, induce an array of psychophysiological changes via two types of nuclear
receptors named mineralocorticoid (MRs) and glucocorticoids (GRs) receptors (de Kloet
et al., 2005).
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Figure 1-1. The schematic graph for the hypothalamus-pituitary-adrenal (HPA)
axis. CRF neurons, the apex of the HPA axis, release CRF (green dots) which triggers
the secretion of the ACTH form the anterior pituitary gland. ACTH in turn stimulates
adrenal glands to release glucocorticoids into the blood stream.
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The physiological effects of GCs are increased cardiac tone, glucose mobilization,
enhanced memory and cognition, increased cerebral blood flow, vasoconstriction and
immune modulation (Sapolsky et al., 2000; Smith and Vale, 2006). In the CNS, both MR
and GR are expressed in various brain regions, and their functions in the hippocampus and
amygdala are well documented with relevance to psychobehavioral response to adverse
events (Lupien et al., 2007; Finsterwald and Alberini, 2014). MR receptors have a tenfold
higher affinity to GCs than GR and are occupied by baseline (i.e. low) levels of GCs. As
such, it has been proposed that MR signaling plays a role in preparing the system for the
initiation of the stress response (Reul and de Kloet, 1985; de Kloet et al., 2005; Finsterwald
and Alberini, 2014). On the other hand, the lower affinity GRs are generally activated by
higher stress-associated concentrations of GCs, and therefore drive various stress
responses. Notably, GRs mediate memory consolidation which could modify future stress
response (de Kloet et al., 2005; Lupien et al., 2007). Another important aspect of GR
activation is its roles in the negative feedback regulation of the HPA axis. That is, the
elevated levels of circulating GCs following stress ultimately act at multiple brain regions
involved in the HPA axis regulation and terminate the activity of the HPA axis. The PVN
is one of the key loci of GC-GR signaling suppressing the HPA axis activity (Smith and
Vale, 2006; Tasker and Herman, 2011).
Besides their stress-regulatory actions, GCs are potent anti-inflammatory
mediators. Indeed, inflammation-induced activation of the HPA axis and the subsequent
release of GCs are critical fine tuning the inflammatory response. The impairment of GC
mediated fine tuning of the inflammatory response can result in an uncontrolled
inflammation such as septic shock (Hench et al., 1949; Sapolsky et al., 2000; Silverman et
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al., 2005). This thesis primarily focuses on understanding the neuronal mechanisms by
which inflammation activates the HPA axis.

1.3   The PVN
The PVN is located bilaterally on the side of the third ventricle (Figure 1-2) and
forms a dense cluster of cell bodies. In rats, it contains approximately 20,000 cells
occupying about 0.3 mm3 (Swanson and Sawchenko, 1983; Kiss et al., 1991). Importantly,
the PVN is composed of a highly heterogeneous cell population: it contains different types
of neuroendocrine neurons that can be classified by the types of neuropeptide expressed,
the size of the cell bodies, their localization within specific intra-PVN subdivisions, and
the projection targets (the details will be discussed below). In addition, there are nonneuroendocrine neurons that send their primary projections to the brainstem and spinal
cord, and thereby influence the sympathetic tone, e.g. increases heart rate and blood
pressure (Swanson and Sawchenko, 1983; Stern, 2001).

1.3.1   Different neuronal subtypes in PVN
1.3.1.1  

Magnocellular neurons

Magnocellular neurons (MNC) are housed in 3 subdivisions of the PVN (anterior,
medial and posterior magnocellular subdivisions) and characterized by their relatively
large cell size (the soma diameters between 20-30 µm). They synthesize both oxytocin
(OXY) and vasopressin (AVP or antidiuretic hormones, ADH). These cells send axonal
projections to the neurohypophysis where posterior pituitary hormones are stored and
released into the blood stream (Swanson and Sawchenko, 1983; Tasker and Dudek, 1991;
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Benarroch, 2005). OXY is important in inducing the milk-ejection reflex during lactation
and uterine contraction during labour. In response to blood volume changes, OXY is
secreted by MNC to regulate body fluids (Leng et al., 1999). AVP has strong antidiuretic
effects to maintain body fluid volume, osmolarity, and vasoconstriction in response to
dehydration and hypovolemia (Leng et al., 1999; Amiry-Moghaddam and Ottersen, 2003).

1.3.1.2  

Parvocellular neurons

The parvocellular neurons are characterized by their relatively smaller cell size (the
soma diameters between 10-25 µm) and located within five distinct regions in the PVN
which are the periventricular, anterior, medial, dorsal and lateral parts of the parvocellular
subdivisions (Swanson and Sawchenko, 1983; Tasker and Dudek, 1991). Based on their
projection targets, theses neurons can be further classified into two neuronal subtypes
including neuroendocrine parvocellular neurons (PNCs) and pre-autonomic (PA)
parvocellular neurons. PNCs are primarily located medially to the parvocellular division
of the PVN (Luther et al., 2002). They send projections to the median eminence where they
release anterior pituitary hormones including CRF, thyrotropin-releasing hormones (TRH),
and somatostatin (Stern, 2015). As we discussed in section (1.2), CRF producing neurons
in the PVN are the principle regulator of the HPA axis which is the focus of this study.
On the other hand, PA neurons send projections to the brainstem and spinal cord,
and regulate the autonomic response (Stern, 2001). These neurons are generally positioned
dorsal and ventral to the parvocellular division of the PVN (Luther et al., 2002). PAs in the
PVN is a vital center in cardiovascular control, including circadian variation of the blood
pressure (Cui et al., 2001), blood-volume regulation (Lovick et al., 1993), and the

7

cardiovascular response to psychological stress (Jansen et al., 1995; Stern, 2001; Nunn et
al., 2011). Moreover, hyperactivity of PAs are implicated in the elevated sympathetic
activity associated with congestive heart failure (Patel and Zhang, 1996; Patel, 2000).
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Figure 1-2. The distribution of different types of neurons in the PVN. The
abbreviations are neuroendocrine corticotrophin-releasing hormone (neCRH),
neuroendocrine

thyrotropin-releasing

hormone

(neTRH),

neuroendocrine

somatostatin (neSS), neuroendocrine tyrosine hydroxylase (neTH), neuroendocrine
vasopressin (neVAS), neuroendocrine oxytocin (neOXY), and neuroendocrine
growth-hormone releasing hormone (neGRH). Adapted from Simmons et al., 2009.
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a

b

c

Figure 1-3. Electrophysiological properties of PVN neurons. a) Magnocellular
neurons exhibit a transient outward rectification characterized by a delay to the first
spike and a dampening of the membrane charging curve. b) Parvocellular
neuroendocrine neurons do not express a transient outward rectification and a low
threshold spike. c) Parvocellular autonomic neurons generate a low threshold spike
shown as the thick line. Adapted from Tasker et al., 2000.
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1.3.2   Electrophysiological properties of different neuronal subtypes in
the PVN
With regard to studying PVN neurons using electrophysiology, earlier studies have
established that different subclasses of PVN neurons have distinct electrophysiological
properties (i.e. fingerprints) that can be used to identify the neuronal subtypes while
performing patch-clamp experiments (Tasker and Dudek, 1991; Luther et al., 2000). For
example, MNCs exhibit, in response to steps of depolarizing current injections, a prominent
delay to the first action potential with a transient outward rectification (Figure 1-3. a). This
delay is primarily mediated by A-type voltage-gated potassium channels sensitive to 4Aminopyridine (Tasker and Dudek, 1991; Luther et al., 2000). PA neurons can be
distinguished from other neuronal subtypes in the PVN based on the expression of the lowthreshold spike driven by T-type Ca2+ conductance (Figure 1-3. c, Tasker and Dudek,
1991; Luther et al., 2000; Stern, 2001). PNCs, on the other hand, are characterized by the
absence of prominent A-type K+ conductance and low-threshold T-type Ca+ conductance
(Figure 1-3. b, Luther et al., 2002).

1.4   Stress-induced activation of the HPA axis
While a stressor can be any type of sensory information that is perceived as a threat
to homeostasis, it can be divided into two major categories: physiological and
psychological stressors. It is generally believed that these different modalities of stressors
recruit distinct neuronal pathways that ultimately converge into the PVN in order to
activate the HPA axis (Figure 1-4). For example, psychological stressors, such as exposure
to a novel environment and restraint stress (two commonly used stress paradigm in rats and
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mice), recruit several cortico-limbic structures including the prefrontal cortex,
hippocampus, and amygdala (Herman and Cullinan, 1997; Ulrich-Lai and Herman, 2009).
These structures do not send direct projection to the PVN but instead connect to a number
of hypothalamic (e.g. dorsomedial hypothalamus (DMH)) and peri-hypothalamic (e.g. the
bed nucleus of stria terminalis (BNST)) nuclei which in turn send monosynaptic afferents
to the PVN neurons (Ulrich-Lai and Herman, 2009; Bains et al., 2015). These multi-layered
regulatory mechanisms have been proposed to be important for the processing and
integration of psychological stress that is in essence “anticipatory”. For example, stored
information from previous stress exposure can modify the subsequent stress response
leading to sensitization and/or desensitization to particular psychological stressor (Herman
and Cullinan, 1997; Ulrich-Lai and Herman, 2009; Bains et al., 2015).
By contrast, physiological stimuli such as hypoxia, inflammation, and pain are real
(physical) disturbances to the haemostasis. It has been shown that these physiological
stressors activate the brain stem nuclei that send direct monosynaptic projections to PNCs
in the PVN (Herman and Cullinan, 1997; Ulrich-Lai and Herman, 2009). Indeed, it has
been demonstrated that the ascending catecholamineregic (i.e. adrenaline and
noradrenaline) projections from the brain stem to the PVN (and other hypothalamic and
supra-hypothalamic structures) are essential for the HPA axis response to physiological
stressors, such as systemic injection of an inflammatory cytokine interleukin (IL)-1β (Li et
al., 1996; Buller et al., 2001; Ulrich-Lai and Herman, 2009). However, precise neuronal
circuits mediating different stressor modalities remain largely unknown. Moreover, how
psychological and physiological stressors can be integrated and influence each other at the
level of the PVN and its upstream cortico-limbic circuits remains unexplored. This thesis
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aimed to clarify specific synaptic mechanisms that may mediate inflammatory stress
signals to the PVN PNCs, and investigated how the identified synaptic mechanisms can be
modulated by psychological stressor with relevance to potential interaction mechanisms
for psychological and physiological stressors.
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Figure 1-4. Neuronal circuitry pathways involved in physiological and psychological
stressors. The abbreviations are prefrontal cortex (PFC), bed nucleus of stria terminalis
(BNST), corticotropin-releasing factor (CRF), and adrenocorticotropic hormone (ACTH).
Adopted from Bains et al., 2015.
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1.4.1   Inflammation and the HPA axis activation
Inflammation is a complex coordinated set of process that can be initiated in the
host tissue in response to trauma, bacterial infection, autoimmune diseases and postischemic events (Nathan, 2002; Barton, 2008). The inflammatory response helps the host
to return to hemostasis state by fighting against the source of inflammation. However, it
also can cause detrimental consequences, in particular when over-activated, including
severe collateral tissue damage, septic shock, multi-organ failure, and ultimately death
(Barton, 2008). The activation of the HPA axis during inflammation, and ensuing antiinflammatory actions of GCs provide a critical negative feedback regulation of the
inflammatory response. An impaired HPA axis function is implicated in septic shock and
autoimmune diseases such as multiple sclerosis (Kapcala et al., 1995; Wei and Lightman,
1997; Ruzek et al., 1999; Silverman et al., 2005).
In order to study the mechanisms of HPA axis activation during inflammation in
animal models, lipopolysaccharides (LPS) and polyinosinic-polycytidylic (poly I:C) have
been commonly used (Sapolsky et al., 1987; Gwosdow et al., 1990; Rivest and Rivier,
1994; Silverman et al., 2005). LPS is the main component of the outer membrane of the
gram negative bacteria which induces a strong inflammatory response (Alexander and
Rietschel, 2001). Toll like receptor (TLR)-4 is essential for the recognition of the LPS by
the immune system (Aderem and Ulevitch, 2000; Medzhitov and Janeway, 2000). Binding
of the LPS to TLR4 initiates a complex intercellular signaling pathway that leads to the
production of the key pro-inflammatory mediators such as cytokine IL-1. Next, these
cytokines mediate their own synthesis and other pro-inflammatory (e.g. IL-6) and anti-
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inflammatory cytokines (e.g. IL-10) (Medzhitov and Janeway, 2000; Konsman et al., 2002;
Mogensen, 2009).
Poly I:C is a double-stranded RNA that mimics viral infections and triggers
immune activation. It has been shown that administration of poly I:C to the animals
(rabbits or mice) results in activation of the HPA axis (Milton et al., 1992; Ruzek et al.,
1999). Collectively, inflammation associated with both bacterial and viral infection triggers
HPA axis activation. Notably, research to date has demonstrated that inflammationmediated activation of the HPA axis is modulated mainly by prostaglandin (PG)E2
(Morimoto et al., 1989; Rivier and Vale, 1991).

1.5   Prostaglandin E2 and neuroendocrine stress response
1.5.1   Prostaglandin E2 synthesis
Prostanoids are a group of fatty acids derived from phospholipids comprising the
cellular membrane. They consist of PGE2, PGD2, PGI2, PGF2α, and thromboxane A2
(Sugimoto and Narumiya, 2007). The activation of phospholipase A2 cleaves arachidonic
acids from the membrane phospholipids. Next, cyclooxygenase (COX) enzyme converts
arachidonic acids into PGH2 which is subsequently mobilized into the different
prostaglandins (PGs) by specific synthases (Narumiya et al., 1999; Kalinski, 2012). There
are two subtypes of the COX enzyme commonly known as COX1 (constitutive COX
enzyme) and COX2 (inducible COX enzyme). It has been shown that systemic
administration of LPS or proinflammatory cytokines, such as IL-1β, induce COX2
expression in the brain vasculature (endothelial cells and/or perivascular macrophages,
Breder and Saper, 1996; Cao et al., 1996; Quan et al., 1998). This lead to the prevailing
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view that circulating afferent inflammatory signals are transduced to PGE2 at the cerebral
vasculature. Owing to its small size and lipophilic properties, PGE2 in turn diffuses into
the brain and recruits neural responses that ultimately activate the HPA axis command
neurons (CRF neurons in the PVN, Schiltz and Sawchenko, 2002, Jc and Pe, 2003, GarcíaBueno et al., 2009).
PGs exert a wide range of action in various organs and tissues. A large bulk of
evidence suggests that among different subtypes of PGs, PGE2 has a key role in regulating
the HPA axis response to inflammation (Morimoto et al., 1989; Rivier and Vale, 1991). It
has been shown that indomethacin (COX inhibitor) significantly attenuates the LPSinduced rise of circulating ACTH, indicating a role of PGs in the activation of the HPA
axis (Matsuoka et al., 2003; Furuyashiki and Narumiya, 2011). Moreover, microinjection
of PGE2 into the rat hypothalamus strongly increased the level of the ACTH in the plasma
suggesting that PGE2’s actions in the hypothalamus activate the HPA axis (Morimoto et
al., 1989; Katsuura et al., 1990). In ex vivo brain slices, electrophysiological studies showed
that application of PGE2 increases the spike frequency of PNCs neurons suggesting that
local actions of PGE2 (i.e. in a reduced brain slice) excite PNCs (Ferri and Ferguson, 2005,
Ferri and Ferguson, 2003).

1.5.2   Prostaglandin E2 receptors and the stress response
PGE2 exerts its action through four G-protein-coupled receptors (GPCR) EP1, EP2,
EP3, and EP4 distributed widely throughout the body (Figure 1-5, Sugimoto and
Narumiya, 2007). Based on the G-protein α subunits, these receptors are divided into three
categories: 1) EP1 receptors linked with Gαq which lead to an increase in the intracellular
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Ca2+ level, 2) EP2 and EP4 receptors linked with Gαs which activate adenylate cyclase and
increase the level of cyclic adenosine monophosphate (cAMP) in the cells, 3) EP3 receptors
coupled with Gαi/o which decrease the level cAMP (Furuyashiki and Narumiya, 2011).
PGE2 receptors are involved in both febrile and neuroendocrine stress response to sickness
model (LPS administration, Furuyashiki and Narumiya, 2009). Using mice lacking PGE2
receptors subtypes, it has been reported that LPS-induced ACTH release was abolished in
mice deficient in either EP1 or EP3 receptors. In addition, the number of neurons
expressing c-Fos (a marker of neuronal excitation) was decreased in the PVN in mice
lacking either one of these two receptors (Matsuoka et al., 2003b; Furuyashiki and
Narumiya, 2011). These findings indicate that PGE2 acting via EP1 and EP3 receptors
plays a crucial role in the activation of the HPA axis in response to systemic inflammation.
Additionally, results from in situ hybridization and immunohistochemistry revealed that
EP1 and EP3 are expressed in cell bodies and axonal terminals of

PVN neurons,

respectively (Nakamura et al., 2000; Oka et al., 2000). The existence of both EP1 and EP3
receptors in PVN support the findings that these receptors might be involved in modulating
the HPA axis response to inflammation. However, it remains to be examined exactly how
PGE2 contributes to the activation of the HPA axis through EP1 and EP3 receptors. The
mechanism by which PGE2 activates PNC remains not fully understood. Earlier studies
indicated that PGE2 modulates GABA inputs to PNC and alters their excitability (Ferri and
Ferguson, 2003; Ferri et al., 2005).
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Figure 1-5. Prostaglandin E2 receptors subtypes. EP1 receptors coupled with Gq
which increase the intracellular Ca2+ level. EP2 and EP4 receptors linked with Gsα
which increase the level of cAMP in cells. EP3 receptors coupled with Giα which
decrease the level cAMP in cells. Adopted from Furuyashiki et al., 2011.
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1.6   γ-aminobutyric acid (GABA)-mediated synaptic
transmission
1.6.1   GABA synthesis and function
The amino acid γ-aminobutyric acid (GABA) have been discovered over half a
century ago as the major inhibitory neurotransmitter in the mammalian nervous system
(Owens and Kriegstein, 2002). This neurotransmitter which was originally called Factor Ι,
identified in the mammalian brain extracts that inhibited the formation of the impulse by
stretch receptors neurons in crayfish (Elliott and Flow, 1956; Owens and Kriegstein, 2002).
Later on, this substance was identified as GABA (Bazemore et al., 1957). It has been shown
that approximately between one fifth and one sixth of synapses in the brain release GABA
(Somogyi et al., 1998). GABA is primarily produced form L-glutamic acid through the
action of either one of the two glutamic acid decarboxylase (GAD) enzymes commonly
known as GAD 65 and GAD 67 each of which has distinct enzymatic functions and cellular
distributions (Kaufman et al., 1991; Martin and Rimvall, 1993; Owens and Kriegstein,
2002). A vesicular neurotransmitter (VGAT) is responsible for loading GABA into
synaptic vesicles. The elevation of the intracellular Ca2+ within the synaptic terminals,
resulting for example from the arrival of an action potential, triggers the fusion of the
synaptic vesicles with the cell membrane and consequently neurotransmitter release into
the synaptic cleft. A class of plasma-membrane GABA transporter (GATs) is involved in
the rapid removal of the neurotransmitter from the synaptic clefts (Owens and Kriegstein,
2002). Subsequently, GABA is metabolized to succinic acid by GABA transaminase
(GABA- T, Martin and Rimvall, 1993; Tao et al., 2006).
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1.6.2   GABA receptors
GABA exerts its actions through the activation of two main types of receptors
which are the ionotropic GABAA receptors, as well as the metabotropic GABAB receptors
(Wu and Sun, 2015). Among these receptors, GABAA receptor is predominantly involved
in fast synaptic transmission in the CNS, and is the focus of this thesis as the target of PGE2
actions in the PVN.

1.6.2.1  

GABAA receptors

GABA A receptors are ligand-gated ion channels which primarily conduct chloride
(Cl-). The opening of the Cl- channels allows the flow of Cl- across the cell membrane that
follows its electrochemical gradient. In adult neurons, low levels of intracellular Cl(relative to extracellular Cl-) causes influx of Cl- near the resting membrane potential (i.e.
-60 mV) and thus causes hyperpolarization of the post synaptic membrane (Owens and
Kriegstein, 2002; Wu and Sun, 2015). However, in developing neurons, activation of the
GABAA receptors could result in depolarization which is due to higher concentration of
the Cl- within the neuron (Ben-Ari, 2002). GABAA receptor is a heteropentameric ion
channel which consists of 19 different subunits commonly known as α1-6, β1-3, γ1-3, δ,
ε, θ, π, and ρ1-3 (Luscher et al., 2011). Different subunits combinations determine distinct
GABAA receptors in terms of function, structure, and pharmacology (Olsen and Sieghart,
2008; Luscher et al., 2011).

1.6.3   Roles of GABA in the PVN and the HPA axis
The neuroendocrine CRF neurons in the PVN receive dense GABAergic inputs
(Cullinan et al., 2008). Dual hybridization histochemical studies demonstrated that CRH
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neurons express various GABAA receptors subunits including α1-2, and β1-3 (Cullinan
and Wolfe, 2000; Cullinan et al., 2008). Notably, electron microscopic studies have shown
that nearly half (46.2%) of the all synaptic terminals in the medial parvocellular subdivision
of the PVN (where neuroendocrine CRF neurons concentrate) are GABAergic, indicating
that GABA is one of the main neurotransmitters regulating the HPA axis (Miklós and
Kovács, 2002). A substantial body of literature suggests that the GABA-mediated
inhibition tonically constrains CRF neuron excitability and as a consequence the HPA axis
activity (Makara and Stark, 2004; Cullinan et al., 2008). For example, local microinjection
of the GABAA receptors antagonist (bicuculline) into the PVN of unstressed rats robustly
induced c-Fos expression in the medial parvocellular subdivision of the PVN (Cole and
Sawchenko, 2002), indicating that removal from tonic GABA-mediated inhibition is one
mechanism to activate the HPA axis.
Interestingly, it has been shown that following acute restraint stress the inhibitory
action of GABA on PVN neurons was remarkably reduced. This loss of GABAergic
inhibition following stress was due to the down regulation of the KCC2 (the K/Cl
transmembrane transporter) leading to subsequent change in intercellular Cl- concentration
and depolarizing shifts in the reversal potential of GABAA R-mediated currents (Hewitt et
al., 2009; Sarkar et al., 2011; Maguire, 2014).
Combining retrograde tracer and immunohistochemical method, it has been
identified that anterior paraventricular nucleus, anterior perifornical area (this region is part
of the bed nucleus of stria terminalis), peri supra-optic area, anterior hypothalamic, and
dorsomedial hypothalamic nucleus are potential origins for GABAergic projections to the
PVN (Roland and Sawchenko, 1993; Cullinan et al., 2008).
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1.7   Rationale and Aims
1.7.1   Rationale
There is a considerable amount of evidence suggesting that PGE2 plays a key role
in activation of the HPA axis in response to inflammation. However, little is known about
how PGE2 increases the excitability of the CRF neurons in the PVN. Using patch clamp
electrophysiology in ex vivo slices, it has been shown that application of PGE2 increases
the firing frequency of PVN neurons including PNCs. Notably, the results from the same
study showed that bath application of PGE2 decreases the frequency of the IPSPs in PNCs.
Moreover, application of the bicuculline, a GABAA receptors antagonist, into the PVN
containing brain slices mimics PGE2-mediated excitation of the PNCs (Ferri et al., 2005).
Together, these observations suggest that PGE2 blocks GABAergic inputs onto PNCs and
consequently activates HPA axis. However, the precise mechanisms by which PGE2
modulates GABAergic inputs onto PNCs remains to be clarified. Therefore, my thesis
sought to investigate the synaptic mechanisms by which PGE2 modulates GABAergic
synaptic transmission onto PNCs with relevance to the roles of PGE2 in HPA axis
activation. Moreover, it has been shown that prior exposure to psychological stress
significantly increases the HPA axis response to inflammation (Jd et al., 2002). These
finding indicate that psychological stress could modulate the way PGE2 drives HPA axis
activation. My thesis explored the impact of psychological stress on the effects of PGE2
on GABAergic synaptic transmission onto PNCs.
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1.7.2   Aims
Aim 1: To investigate the synaptic mechanism by which PGE2 activates PNCs.
An earlier electrophysiological study has demonstrated that PGE2 increases the
excitability of the PNCs. Importantly, this effect was mediated through suppression of the
GABAergic synaptic transmission (Ferri and Ferguson, 2003; Ferri et al., 2005). However,
the results from this study did not illustrate whether the effect of the PGE2 on GABAergic
inputs is presynaptic or postsynaptic. In order to extend this earlier finding, I performed
patch clamp electrophysiology to tease out the precise locus of PGE2 actions on
GABAergic transmission.
Aim 2: To elucidate which receptor of PGE2 modulates GABA ergic synaptic
transmission.
LPS-induced activation of the HPA axis is impaired in EP1 and EP3 deficient mice
suggesting that these two receptors might have a crucial role in the activation of the HPA
axis (Matsuoka et al., 2003). Among these two receptors, EP3 is primarily coupled with
Gαi/o signaling that can decrease neurotransmitter releases including GABA in many
synapses (Atwood et al., 2014). Thus, I hypothesized that EP3 receptors mediates PGE2induced suppression of the GABA release.
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a

b

Figure 1-6. The schematic diagram of inflammation induced activation of the
HPA axis. A) Inflammation activates the HPA axis, which in turn attenuates
inflammatory responses. B) My hypothetical model that PGE2 activates HPA axis
through inhibition of GABAergic inputs onto CRH neurones.
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Aim 3: To examine whether psychological stress alter PGE2-mediated HPA axis
activation.
No studies to date have investigated the effect of the psychological stress on PGE2mediated activation of the HPA axis at synaptic and molecular levels. Thus, I hypothesized
that exposure to psychological stress alters the effects of PGE2 on GABAergic synaptic
transmission onto PNCs.
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2  

Material and Methods

2.1   Animal handling and stress
All the experiments involving the use of animals were approved by institutional
care and use committee of the University of the Western Ontario in accordance with the
guideline of the Canadian Counsel on Animal care. Experiments were performed using
male Sprague Dawely rats (Charles River Laboratories, Quebec, Canada) aged between 25
and 45 days. After being shipped from the supplier, the animals were acclimatized to the
institutional facility for minimum 5 days before any experiments. The animals were kept
in a 12 h/12 h light–dark cycle (lights on at 7:00 AM). Food and water were provided ad
libitum. Every effort was made to prevent causing any unnecessary distress to the animals.
For the stress experiments, rats were confined within a well-ventilated Plexiglas cylinders
that restricts their movement for 30 min. Restraint was performed during the light phase,
between 12:00 and 1:00 PM, for either 1 or 5 consecutive days. Immediately after the last
immobilization stress, animals were deeply anesthetized with isoflurane and decapitated to
prepare brain slices.

2.2   Slice preparation
The brain was quickly removed and immersed into ice-cold slicing solution (95%
O2, 5% CO2 saturated) containing (in mM: NaCl 87, KCl 2.5, NaHCO3 25, MgCl2 7,
NaH2PO4 1.25, glucose 25, and sucrose 75). Coronal hypothalamic slices (300 µm) were
prepared using a vibratome (VT1200s, LEICA). Slices containing the PVN were identified
based on the macroscopic features and placed into a slice camber filled with artificial
cerebrospinal fluid (aCSF) containing (in mM; NaCl 126, KCl 2.5, NaHCO3 25, MgCl2
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1.2, NaH2PO4 1.2, glucose 11, and CaCl2 2.5) constantly bubbled with 95% O2, 5% CO2.
The slice chamber was maintained at 35 °C for 30 min for the recovery of slices, and
thereafter kept at room temperature for a longer storage of slices. Before the recording
process, the slice was transferred to the recording chamber constantly perfused with aCSF
(30 °C, saturated with 95% O2, 5% CO2) at a flow rate of 1-2 ml per min.
°

2.3   Electrophysiology
All recordings were performed using whole-cell patch clamp configuration. Under
an infrared differential interference contrast microscope (BX51WI, Olympus), PVN
neurons were visually identified based on their morphology, and PNCs were selected based
on their location, morphology and electrophysiological characteristics in a current-clamp
configuration (Tasker and Dudek, 1991). Borsosilicate glass microelectrode (2-4 MΩ)
were pulled using a Flaming/Brown type micropipette puller (P1000, Sutter Instrument,
CA, USA) and filled with intracellular solution consisted of (in mM: K-gluconate 123,
NaCl 8, EGTA 1, HEPES 16, MgCl2 2, K2ATP 4, and Na3GTP 0.3). The osmolality of the
intracellular solution was between 283 and 289 mOsm. Moreover, its pH was adjusted
between 7.2 and 7.4 by using KOH. For the whole cell recording, a gigaseal was obtained
followed by patch rupture, which was achieved by applying a brief suction.
In the voltage-clamp experiments, PNCs were clamped at -68 mV and recordings
were obtained at 30°C. During the whole process of recording, an AMPA kainate receptor
antagonist, 6,7-dinitroquinoxaline-2,3-dione (DNQX; 10 µM, Tocris Bioscience) was
perfused constantly to isolate fast GABAA receptor-mediated inhibitory postsynaptic
currents (IPSCs). In experiments where TTX (0.5 µM) was added, PGE2 was not applied
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until action potentials were completely blocked. Access resistance was monitored every 5
min, and recordings were discarded if the value exceed 20 MΩ or changed more than 20%
from the baseline.
A glass electrode filled with aCSF was placed medial to the recorded neuron to
evoke a pair of IPSCs 50 ms apart and at the rate of 0.2 Hz. Using this electrode, I
stimulated GABAergic synapses projecting to the PVN. The duration of the stimulation
was 1 ms and the intensity of the stimulation was between 6 to 9 V. As I discussed in
section (1.6.3) the potential origins of these projections are anterior paraventricular
nucleus, anterior perifornical area (this region is part of the bed nucleus of stria terminalis),
peri supra-optic area, anterior hypothalamic, and dorsomedial hypothalamic nucleus
(Roland and Sawchenko, 1993; Cullinan et al., 2008). Indeed, these inputs are not
composed of any pathway or neuronal tract. Instead, these GABAergic terminals are
intermingled with neurons in the PVN.

2.4   Drugs
PGE2 (cat#: 14010 ), Sulprostone (cat#: 14765 ), L-798,106 (cat#: 3342) were
obtained from Cayman Chemical (city, USA), dissolved in 100% ethanol and kept at -20°C
as aliquot, and diluted to appropriate concentration as required. The maximum
concentration of ethanol in the final working solution was 0.2%. TTX (cat#: T-550) was
obtained from Alomone labs (Jerusalem, Israel).
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2.5   Data collection, analysis and statistics
Recordings were amplified using Multiclamp 700B (Molecular Devices), low pass
filtered at 1 kHz, and digitized at 10 kHz with a Digidata 1440 A (Molecular Devices).
Signals were recorded (pClamp 10.1, Molecular devices) and stored in the computer for
offline analysis. Evoked IPSC (eIPSC) amplitudes were calculated by subtraction of peak
synaptic currents from pre-stimulation baseline currents. Spontaneous IPSCs were
analyzed using MiniAnalysis (Synaptosoft) and confirmed as synaptic events by visual
analysis. Data was normalized and presented as a percentage of baseline value (0-5 min
before treatment). Post-treatment values were examined 5 to10 min after application of the
drugs. Frequency and amplitude of eIPSCs, paired-pulse ratio (amplitude of 2nd eIPSC/1st
eIPSC), and coefficient of variation (CV, standard deviation/mean) were analyzed for 5
minute bins. Data was presented as mean ± s.e.m. Statistical significance was tested using
parametric t-test in all experiments. To analyze the correlation between two variables,
linear regression analysis was applied. A probability values < 0.05 was considered
statistically significant. All statistical analysis were performed using the GraphPad Prism
7 (GraphPad Software Inc., CA, USA).
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3  

Results

3.1   PGE2 inhibits GABAergic synaptic transmission onto
PNCs
My hypothesis was that PGE2 attenuates GABAergic synaptic transmission onto
PNCs. To test this hypothesis, I examined the effects of PGE2 on GABAergic inhibitory
postsynaptic currents (IPSCs) in a whole-cell voltage clamp configuration. Consistent with
previous data, I found that bath application of PGE2 (10 µM for 5 min) robustly decreased
the amplitude of eIPSCs (54.94 ± 8.8 % of the baseline, p = 0.001, n = 9, Figure 3-1 a, b).
This finding indicates that the release from GABA-mediated inhibition could be one
possible mechanism by which PGE2 modulates HPA axis activation. Notably, the effect of
PGE2 was long-lasting, persisted for the duration of the stable recording >25 min after the
washout. PGE2 dose-dependently (0.01-100 µM) attenuated eIPSCs with the maximum
effect reaching at 10 µM (Figure 3-1 d).
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a

b

c

d

Figure 3-1 PGE2 decreases the amplitude of eIPSCs. (a) Sample traces of eIPSC
before (black) and after (red) PGE2 application recorded from rats hypothalamic slices.
(b) Representative time-course of eIPSC amplitude. The horizontal bar indicates the
time of PGE2 application (c) Summary time-course of eIPSCs amplitude. PGE2
significantly decreased the amplitude of eIPSCs (0-5 min vs. 10-15 min, p = 0.001, n
=9 ). The horizontal line represents the time of PGE2 application. Data are mean ± s.e.m.
(d) Dose-response relationship for PGE2 inhibition of IPSCs. The EC50 is calculated to
be 4.55 ⋅ 10 -6 M.
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3.2   PGE2-mediated GABA synapse depression involve
presynaptic mechanisms
Our finding demonstrated that PGE2 attenuated GABAergic synaptic transmission
to PNCs. PGE2 could modulate this effect either through presynaptic mechanisms
(decrease in probability of the neurotransmitter release) or postsynaptic mechanisms
(modulation of the post synaptic receptors function) as illustrated in Figure 3-2. To tease
out the locus of the PGE2-induced depression of GABAergic synaptic transmission, I
analyzed the concomitant changes in the paired-pulse ratio (PPR) and coefficient of
variation (CV) of the eIPSCs (Figure 3-3 a). According to a widely-accepted model of
synaptic transmission, if the depression of eIPSC involves a decrease in the probability of
the neurotransmitter release (Pr), it should be accompanied by an increase in PPR as well
as a decrease in 1/CV2 (Table 3-1, Korn and Faber, 1991; Branco and Staras, 2009). In line
with this prediction, PGE2 significantly increased the PPR (136.6 ± 10.75 % of baseline,
p = 0.0092, n=9). Similarly, PGE2 decreased 1/CV2 (45.06 ± 11.4 % of baseline, p =
0.0014, n = 9). We also plotted the changes in PPR and 1/CV2 against eIPSCs amplitude
in each individual cell to investigate more closely the relationship between PPR, 1/CV2,
and GABA synapse depression (Figure 3-3 b). Our data showed that there is a strong linear
negative correlation between PPR and eIPSCs (R2=0.32, p=0.0001), and also a positive
linear correlation between 1/CV2 and eIPSCs amplitude (R2=0.59, p< 0.0001).
The analysis of spontaneous IPSCs (sIPSCs) revealed that that PGE2 (10 µM)
decreased the frequency of sIPSCs (38.12 ± 6.4 % of the baseline, p = 0.0002, n = 6,
Figure 3-4 a, d). Again, this observation is consistent with the decrease in Pr from the
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presynaptic terminals. By contrast, PGE2 did not affect the mean amplitude of the sIPSCs
(99.61± 6.2 % of the baseline, p = 0.9, n = 6, Figure 3-4 b, d), indicating that PGE2 did
not change postsynaptic receptor function. Table 3-1 summarizes the changes of
biophysical parameters associated with the PGE2-induced eIPSC suppression. The changes
in these parameters could determine whether PGE2 modulates GABAergic synaptic
transmission through presynaptic or post synaptic mechanisms. Collectively, our finding
showed that application of the PGE2 was accompanied by an increase in PPR and a
decrease in 1/CV2 and sIPSCs frequency. As indicated in Table 3-1, these changes
represent the decrease in Pr from the presynaptic terminals.
Next, in order to examine whether or not the effect of PGE2 is action potentialdependent, I applied tetrodotoxin (TTX, 0.5 µM) to block voltage-gated Na+ channels. Our
results showed that, in presence of TTX, PGE2 (1-10 µM) significantly decreased the
frequency of miniature IPSCs (mIPSCs) (17.6 ± 4.05 % of baseline, p <0.0001, n = 5,
Figure 3-4 d) without showing any significant effect on the average amplitude (101 ± 4.5
% of baseline, p = 0.8, n = 5). These findings indicate that the inhibitory effect of PGE2 on
GABAergic synaptic transmission is through action-potential independent mechanisms.
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a

PGE2

b

PGE2

c

PGE2

Figure 3-2. Potential mechanisms for PGE2-induced suppression of the GABA synapse.
a) PGE2 could decrease the probability of the neurotransmitter release. b) PGE2 could
modulate the post synaptic receptors. c) PGE2 could shut down the synaptic transmission by
both inhibiting the neurotransmitter release and eliminating the post synaptic receptors.
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Table 3-1. Changes of synaptic properties associated with different types
of synaptic plasticity. The table illustrates how the decrease in probability of
release (Pr), numbers of synapses (n), quantal size (q) change paired pulse ratio
(PPR), 1/CV2, spontaneous Inhibitory Postsynaptic Currents (sIPSCs)
frequency, and amplitude.

PPR
Pr
n
q

1/CV2

sIPSCs
sIPSCs
amplitude frequency
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Figure 3-3. PGE2 application is accompanied by a decrease in neurotransmitter
release probability. (a) Summary time-course of amplitude (white), PPR (red), and
1/CV2 (blue) of eIPSCs recorded in slices contained PNCs from Sprague Dawley
rats. The horizontal bar indicates the time of PGE2 application. (b) Plots of 1/CV2
(blue) and PPR (red) versus amplitude after PGE2 application recorded from PNCs.
The blue and the red solid lines represent the best fit linear regression for 1/CV2 (r2
= 0.59, P < .0001) and PPR (r2 = 0.32, P = 0.0001), respectively.
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Figure 3-4. PGE2 does not change the quantal amplitude. (a) Sample traces of sIPSC
before (black) and after (red) PGE2 application recorded in rats hypothalamic slices. (b)
Superimposed recording of 5 min of sIPSC before (black) and after (red) PGE2 application.
Solid traces depict the average of sIPSCs before (black) and after (red) bath application of
PGE2. (c) Representative time-course of sIPSCs amplitude (blue square) and frequency (red
bar). The horizontal bar illustrates the time of PGE2 application. (d) Summary time-course
of normalized sIPSC amplitude (blue, p = 0.9, n = 6), frequency (red, p = 0.0002, n = 6), and
frequency with TTX (gray, p <0.0001, n = 5). The statistical evaluation was parametric t-test
for post-treatment (10-15 min) versus pre-treatment (0-5 min) data. Data are mean ± s.e.m.
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3.3   PGE2-EP3 signaling modulates GABA release onto PNCs
PGE2 acts through four GPCRs receptors EP1-4 (Sugimoto and Narumiya, 2007).
It has been shown that LPS-induced activation of the HPA axis is impaired in EP1 and EP3
deficient-mice suggesting that both EP1 and EP3 receptors might be involved in ACTH
secretion in response to LPS (Matsuoka et al., 2003). Immunohistochemistry and combined
in situ hybridization histochemistry studies have shown EP3 expression in the
hypothalamus (Ek et al., 2000; Nakamura et al., 2000). Moreover, the EP3 receptor is
primarily coupled to the Gi/oα-protein subunit which can decrease the probability of
neurotransmitter release from presynaptic terminals (Atwood et al., 2014). Combining
these evidences, we hypothesized that EP3 is responsible for the PGE2-induced GABA
synapse depression. To address the hypothesis, we applied EP3 agonist (sulprostone 1 µM).
Similar to PGE2, bath application of sulprostone for 5 min resulted in a reduction of the
eIPSCs amplitude (60.7 ± 9.6% of baseline, p = 0.0036, n = 9, Figure 3-5 a, b, c).
Furthermore, the depression of eIPSCs was accompanied by an increase in PPR and a
decrease in 1/CV2, suggesting the decrease in Pr is similar to the case of PGE2. We also
examined the effect of sulprostone on the frequency and amplitude of the sIPSCs, and
found that sulprostone decreased the frequency (47% ± 15 of baseline, p < 0.05, n = 5)
without changing the mean amplitude of sIPSCs (95% ± 4.9 of baseline, p = 0.4, n = 5,
Figure 3-6 a, b, c).

a

b

c
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d

Figure 3-5. EP3 agonist mimics the effect of PGE2. (a) Individual (thin line) and
average (solid line) trace of eIPSC before (black) and after (blue) sulprostone (EP3
agonist, 1 µM) application recorded from rat hypothalamic slices. (b) Representative
time-course of eIPSCs amplitude. The time of Sulprostone application is shown by
horizontal bar. (c) Summary time-course of normalized eIPSC amplitude (blue), 1/CV2
(purple), and PPR (red). Sulprostone significantly decreased the amplitude of eIPSCs (05 min vs. 10-15 min, p = 0.0036, n = 9). Data are mean ± s.e.m. (d) Plots of normalized
1/CV2 (red), and PPR (blue) versus amplitude 5 to 10 min after Sulprostone application.
The blue and the red solid lines represent the best fit linear regression for 1/CV2 and PPR,
respectively.
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Figure 3-6. EP3 agonist mimics the effect of PGE2. (a) Sample traces of sIPSCs before
(black) and after (blue) application of the EP3 agonist recorded from PNCs. (b) Summary
time-course of the sIPSCs frequency. Sulprostone significantly decreased the frequency of
sIPSCs (0-5 min vs. 10-15 min, p = 0.018, n = 5). Data are mean ± s.e.m. (c) Summary
time-course of amplitude of the sIPSCs. Sulprostone did not change the amplitude of
sIPSCs (0-5 min vs. 10-15 min, p = 0.4, n = 5). The horizontal bar indicates the time of
the sulprostone (EP3 agonist) application. Data are mean ± s.e.m.
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Next, as a complementary experiment, I examined the effect of an EP3 antagonist
(L-798, 106, 100µM) on PGE2-induced suppression of eIPSCs. For this part of the
experiment, PGE2 was bath applied in the presence of the L-798, 106 (EP3 antagonist). I
found that L-798, 106 (100 µM) completely blocked the effect of the PGE2 (1 µM) (110 ±
8.4 % of baseline, p = 0.247, n = 8, Figure 3-7 a, b, c). Furthermore, in the presence of L798, 106, PGE2 did not change PPR (106 ± 6.6 % of baseline, p= 0.38) or 1/CV2 (104 ±
14.02 % of baseline, p=0.73). Moreover, when sIPSCs were examined, L-798, 106 did not
change the frequency (116.9 ± 14.8 % of baseline, p = 0.3, n = 6) or the amplitude (102.5
± 3.5 % of baseline, p = 0.51, n = 6, Figure 3-8 a, b, c). Collectively, my data indicate that
PGE2 suppresses GABAergic synaptic releases through pre-synaptic EP3 receptors.
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Figure 3-7. Ep3 antagonist blocks the effect of PGE2. (a) Individual (thin line) and average
(solid line) trace of eIPSC before (black) and after (green) EP3 antagonist (L-798 106, 100µM)
+ PGE2 application. (b) Representative time-course of eIPSCs amplitude.(c) Summary timecourse of normalized eIPSCs amplitude (green), 1/CV2 (purple), and PPR (pink). Application of
PGE2 + EP3 antagonist did not decrease the amplitude of eIPSCs (0-5 min vs. 10-15 min, p =
0.274, n = 8). Data are mean ± s.e.m. (d) Percent change in eIPSC amplitude from the baseline
after application of the PGE2 (red), sulprostone (blue), and EP3 antagonist (L-798 106, green).
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Figure 3-8. Ep3 antagonist blocks the effect of PGE2. (a) Sample trace of sIPSCs before
(black) and after (green) PGE2 + EP3 antagonist (L 798 106) application. (b) Summary timecourse of frequency (p = 0.3, of the sIPSCs. PGE2 + EP3 antagonist did not change the frequency
of sIPSCs (0-5 min vs. 10-15 min, p = 0.3, n = 6). (c) Summary time-course of the sIPSCs
amplitude. PGE2 + EP3 antagonist did not change the amplitude of sIPSCs (0-5 min vs. 10-15
min, p = 0.38, n = 6). Data are mean ± s.e.m.
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3.4   Psychological stress impairs PGE2-mediated inhibition of
GABA release.
In addition to inflammation, psychological stress is another modality of stress that
strongly activates the HPA axis. Studies to date have shown that the sensitivity of the HPA
axis to inflammation could be modulated by preceding exposures to psychological stress.
For example, it has been reported that prior exposure to unescapable tail shock significantly
increases HPA axis response to LPS injection in rats (Jd et al., 2002). Considering that both
modalities of stress (physiologic and psychologic) ultimately recruit the same
neuroendocrine stress response, one possibility is that psychological stress may modulate
the sensitivity of afferent synapses onto PNCs to inflammatory signals. Thus, I asked
whether psychological stress modulates the effects of PGE2 on GABAergic synaptic
transmission onto PNCs. In order to test this, the rats were subjected to restraint stress for
30 min, and immediately sacrificed to produce acute brain slices. I found that, in slices
from stressed rats, PGE2 did not significantly affect the amplitude of the eIPSCs (p > 0.05,
n = 9, Figure 3-9 a, b, c), indicating that PGE2-induced suppression of GABA release is
lost following acute stress. Interestingly, however, sulprostone (1 µM, EP3 agonist) still
decreased the amplitude of the eIPSCs (74.24 ± 8.5% of baseline, p = 0.02, n = 6, Figure
3-10. a, b, c), similar to what I observed in naïve animal. This indicates that following
acute psychological stress, EPs other than EP3 are recruited to counteract the EP3-mediated
suppression of GABA release.
Next, I examined the effects of sub-chronic psychological stress on PGE2-mediated
GABA release suppression. To this end, I obtained acute brain slices from rats subjected
to daily 30 min restraint stress for 5 consecutive days, and repeated the same experiments.
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Similar to the case of acute stress, I found that PGE2-induced eIPSCs was impaired (78.04
± 13.2% of baseline, p = 0.14, n=8, Figure 3-11 a, b, c) a result similar to the data from 1
day stress experiments. Furthermore, application of the EP3 agonist decreased the
amplitude of eIPSCs (74.24 ± 11.28% of baseline, p = 0.08, n = 5, Figure 3-12 a, b, c).
Collectively, our data demonstrated that that both single and repeated
immobilization stress impair PGE2-induced suppression of the GABA release suggesting
that psychological stress may decrease the excitatory effect of the PGE2 on PNCs (Figure
3-13 a). However, even though there was a trend towards reduced EP3 receptor function,
it was not significantly different from naïve animals. Our findings did not show any
significant differences between the effect of single acute and repetitive restraint stress
(Figure 3-13 b). Interestingly, we have observed variability in neuronal responses to the
PGE2 application, meaning that some synapses exhibit potentiation while other showed
depression. One likely interpretation of these findings is that after psychological stress
other receptors might be involved in PGE2-induced potentiation of the GABA release that
masks EP3-mediated depression.
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Figure 3-9. Acute stress modulates PGE2-mediated suppression of GABA release. (a)
Individual (thin line) and average (solid line) traces of eIPSCs before (black) and after (pink)
application of PGE2 recorded from stressed animal. (b) Representative time-course of eIPSCs
amplitude. The horizontal bar represents the time of PGE2 application. (c) Summary timecourse of eIPSCs amplitude (pink), PPR (red), and 1/CV2 (purple). PGE2 did not change the
amplitude of eIPSCs (0-5 min vs. 10-15 min, p > 0.05, n = 9). The horizontal bar shows the
time of PGE2 application. Data are mean ± s.e.m.
e  
f  
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Figure 3-10. Acute stress does not modulate EP3 -mediated suppression of GABA release.
(a) Individual (thin lines) and average (solid line) traces of eIPSCs before (black) and after
(purple) sulprostone (EP3 agonist) application recorded from stressed animal. (b)
Representative time-course of eIPSCs amplitude. The bar indicates the time of sulprostone
(EP3 agonist) application. Data are mean ± s.e.m. (c) Summary time-course of eIPSCs
amplitude (purple) p = 0.02, n = 6), PPR (red), and1/CV2 (light purple). Sulprostone
significantly decreased the amplitude of eIPSCs (0-5 min vs. 10-15 min, p = 0.02, n = 6). The
horizontal bar represents the time of sulprostone (EP3 agonist) application. Data are
mean±s.e.m.
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Figure 3-11. Chronic stress impairs PGE2-mediated suppression of GABA release.
(a) Individual (thin line) and average (solid line) traces of eIPSCs before (black) and
after (dark brown) application of PGE2 recorded from stressed animal. (b)
Representative time-course of eIPSCs amplitude. The horizontal bar represents the time
of PGE2 application. (c) Summary time-course of eIPSCs amplitude (dark brown), PPR
(red), and 1/CV2 (light purple). PGE2 did not change the amplitude of the eIPSCs (0-5
min vs. 10-15 min, p = 0.14, n = 8). The horizontal bar shows the time of PGE2
application. Data are mean ± s.e.m.
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Figure 3-12. EP3 receptor suppresses GABAergic synaptic transmission following
chronic stress. (a) Individual (thin lines) and average (solid line) traces of eIPSCs
before (black) and after (light brown) application of the sulprostone (EP3 agonist)
recorded from stressed animal. (b) Representative time-course of eIPSCs amplitude.
The bar indicates the time of sulprostone (EP3 agonist) application. (c) Summary timecourse of eIPSCs amplitude (light brown), PPR (red), and 1/CV2 (light purple).
Sulprostone decreased the amplitude of the eIPSCs (0-5 min vs. 10-15 min, p = 0.08, n
= 5) The horizontal bar represents the time of sulprostone (EP3 agonist) application.
Data are mean ± s.e.m.
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Figure 3-13. Psychological restraint stress modulates PGE2-mediated
attenuation of the GABA release. (a) Percent change in eIPSCs amplitude from the
baseline after application of the PGE2 in naïve (red), 1 day stressed (pink), and 5 day
stressed (dark brown) animals. (b) Percent change in eIPSCs amplitude after application
of the sulprostone (EP3 agonist) in naïve (blue), 1 day stressed (purple), and 5 day
stressed (light brown) animals.
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Discussion
The primary goal of this study was to identify the mechanisms by which PGE2

activates PNCs in the PVN with relevance to the activation of the HPA axis during
inflammation. To this end, I focused on how PGE2 modulates GABAergic synaptic inputs
onto PNCs, as the removal of GABA-mediated inhibition (i.e. disinhibition) is an
established neuronal mechanisms that drives PNC activity and ensuing HPA axis outputs
(Verkuyl et al., 2004; Hewitt et al., 2009; Sarkar et al., 2011; Bains et al., 2015). The first
part of my thesis established that PGE2 robustly attenuates GABAergic transmission onto
PNCs and demonstrated its presynaptic locus inhibiting the release of GABA. The second
part identified that EP3 receptors are responsible for PGE2-mediated inhibition of GABA
release. These results collectively identified a plausible mechanism by which PGE2
activates PNCs, and as a consequence the HPA axis. In the final part of my thesis, I
explored whether a preceding psychological stress modulates the PGE2-induced
suppression of GABA synaptic transmission, in an effort to uncover synaptic mechanisms
by which an exposure to psychological stress changes the sensitivity of the HPA axis to
inflammation (Jd et al., 2002). I found that following an acute as well as sub-chronic
psychological stress exposure, the inhibitory effects of PGE2 on GABA synaptic
transmission becomes highly variable, some even resulting in an opposite potentiation of
GABAergic transmission. I obtained evidence that the potentiation of GABA synapse is
mediated by EP receptors other than EP3 (i.e. EP1, EP2 or EP4), which only became
evident following psychological stress. Thus, my results suggest a potential synaptic
mechanism where psychological stress modulates the sensitivity of the HPA axis to
inflammatory stress signal PGE2.
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4.1   PGE2 suppresses GABAergic synaptic inputs onto PNCs.
It is well documented that the central actions of PGE2 mediate the activation of the
HPA axis in response to systemic inflammation (Morimoto et al., 1989; Murakami and
Watanabe, 1989; Rivier and Vale, 1991). My thesis examined the GABAergic synapses
onto PNCs as a potential target of PGE2 action and found that PGE2 robustly suppressed
GABAergic transmission to PNCs. Specifically, I showed that PGE2 dose-dependently
decreases the amplitude of the eIPSCs recorded in PNCs in acute brain slices, and the
effects of PGE2 have a rapid onset (< 5 min) after the application of the drug and are long
lasting (< 20 min) after the wash out. My finding extended previous electrophysiological
studies by Ferri and Ferguson reporting that both IL-1β (a cytokine that stimulates PGE2
synthesis) and PGE2 supressed spontaneous GABAergic synaptic transmission to PNCs of
the PVN (Ferri and Ferguson, 2003; Ferri et al., 2005). Also, in line with our results, it has
been

shown that GABAA receptor antagonist bicuculline occluded IL-1β-induced

activation of the parvocellular neurons in ex vivo slice electrophysiology, indicating that a
disinhibition of PNCs is a major mechanism underlying the activation of PNCs in response
to inflammatory stimuli (Ferri et al., 2005). Based on my findings and those by others, I
propose that disinhibition (a decreases in GABAA receptor inhibitory effects) is one
important mechanism by which PGE2 activates PNCs and consequently the HPA axis.
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4.2   PGE2-mediated GABA synapse depression involves
presynaptic mechanisms.
The major finding of my thesis is that PGE2 suppressed GABAergic synaptic
transmission by decreasing Pr from the presynaptic terminals. The evidence that support
this conclusion is two fold: first, we observed that the PGE2-mediated suppression of
eIPSC amplitude is accompanied by an increase in PPR as well as a decrease in 1/CV2
(Figure 3-3. a), well-established changes in synaptic parameters indicative of the decrease
in Pr (Zucker and Regehr, 2002). Indeed, the eIPSC amplitude changes showed strong
negative and positive correlations with the changes in PPR and 1/CV2, respectively (Figure
3-3. b). Second, I found that PGE2 decreases the frequency of sIPSCs with no change in
the amplitude. These results are again in line with the decrease in the release probability
and also indicate that PGE2 had little, if any, effects on the quantal size (i.e. postsynaptic
receptor expression and function).
I found that the effect of PGE2 on sIPSCs was maintained in presence of TTX (an
antagonist for voltage-dependent Na+ channels), indicating that PGE2 decreases the
release of neurotransmitter independent of action potential firing. In the supraoptic nucleus
of the hypothalamus, a previous study has shown that PGE2 similarly decreases the
synaptic release of GABA in the presence of TTX (Ibrahim et al., 1999). Action potentialdependent and -independent synaptic transmission are mediated in large part by
overlapping molecular machinery regulating neurotransmitter release. However, there is a
growing appreciation that there are small, but distinct, populations of synapses specifically
involved in action potential-independent synaptic transmission (Ramirez and Kavalali,
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2011) and that some neuromodulators specifically modulate distinct types of synaptic
transmission (Taniguchi et al., 2000; Glitsch, 2006). Our finding that PGE2 inhibits both
eIPSCs and mIPSCs, with equal potency, suggesting that PGE2 targets neurotransmitter
release mechanism common in both types of synapses and/or nonspecifically both types of
synapses. In contrast to our finding of the PGE2 actions on action potential-independent
mIPSCs, Ferri and Ferguson reported that PGE2-mediated suppression of the GABA
release was abolished in presence of TTX, suggesting that the effect of the PGE2 is action
potential-dependent (Ferri and Ferguson, 2005). This discrepancy may originate from
slight difference in aCSF Ca+2 concentration (2.5 mM in our experiment, 2 mM in Ferri
and Ferguson study) and also thickness of brain slices (300 µm in our study, 400 µm in
Ferri and Ferguson study). In addition, in our experiments, voltage-clamp was performed
for the majority of the recordings, whereas they recorded from the cells using currentclamp configuration. Nevertheless, we do not have a solid explanation for this discrepancy.

4.3   EP3 receptor mediates the inhibition of GABA release
onto PNCs.
Using mice lacking respective PGE2 receptors (EP1-EP4), Matsuoka et al., have
shown that both EP1 and EP3-deficient mice showed an impaired HPA axis response to
systemic LPS administration (Matsuoka et al., 2003). These findings indicate that both EP1
and EP3 are necessary for PGE2-mediated activation of the HPA axis. My results
demonstrate that EP3 mediates the inhibitory effects of PGE2 on GABAergic synaptic
transmission, suggesting that the role of EP3 in the HPA axis likely involve its actions in
the PVN GABA synapses. Consistent with the presynaptic locus of PGE2 action as
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discussed above, the observed EP3-mediated GABA synapse inhibition was accompanied
by the changes in synaptic parameters (PPR, 1/CV2, sIPSC frequency & amplitude). In line
with our findings, histological studies have shown that EP3 proteins are highly expressed
in the axonal terminals of the PVN but not in the cell bodies of postsynaptic neurons
(Nakamura et al., 2000). Similarly, EP3 mRNA are highly expressed in brain regions
known to send GABAergic inputs to the PVN (BNST, DMH, preoptic area (POA)) but
only little, if any, in the PVN (Ek et al., 2000).
It has also been shown that EP3 receptors are indispensable for febrile response to
PGE2 (Ushikubi et al., 1998). The POA is the major site in the brain involved in illnessinduced fever. EP3-expressing POA neurones are GABAergic and are shown to project
directly to the PVN (Nakamura et al., 2000, 2002; Ulrich-Lai and Herman, 2009). Thus, it
has been proposed that PGE2 mediates fever response through suppression of these
neurones. Additionally, similar to PGE2, local microinjection of the muscimol (GABAA
receptors agonist) into the POA increases body temperature (Nakamura et al., 2002). These
findings raise a possibility that the mechanism by which EP3 activates PNCs might be
similar to EP3-mediated fever response.
Furthermore, PGE2 also depolarises putative pre-autonomic neurons in the PVN
that subsequently increase the sympathetic tone. Interestingly, PGE2-mediated
sympathetic activation is modulated by EP3 receptors (Zhang et al., 2011).

4.3.1   EP3 Gαi/o-GPCR signaling and synaptic transmission
As I discussed earlier in this thesis, the EP3 receptor is a GPCR coupled with Gαi/o
that inhibits adenylyl cyclase and decreases downstream cAMP signaling. A wide variety
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of Gi-coupled GPCR, when expressed in the presynaptic terminals, decrease
neurotransmitter release and synaptic efficacy (Atwood et al., 2014). Mechanistically, a
decrease in the intracellular cAMP and subsequent reduction in the activity of the protein
kinase A (PKA) have been linked to the inhibition of presynaptic voltage-dependent Ca+2
channels (VDCCs). The inhibition of the VDCCs results in reduced vesicle docking and
probability of neurotransmitter release (Mato et al., 2008; Atwood et al., 2014). For
example, using patch-clamp electrophysiology, it has been reported that application of a
VDCCs blocker (cadmium chloride) occludes CB1R Gαi/o-GPCR mediated suppression of
the fast GABAergic synaptic transmission in rats pyramidal neurons suggesting that the
effect of CB1 receptors on GABA release is likely due to inhibition of the VDCCs
(Hoffman and Lupica, 2000). Similarly, mGluR7 Gαi/o-GPCR mediated LTD (long term
depression) induced in mossy fiber (MF) synapses onto hippocampus stratum lucidum
following high frequency stimulation (HFS) requires inhibition of the VDCCs (Pelkey et
al., 2006). Together, these findings suggest that EP3 mediated suppression of GABA
release could be likely be due to the inhibition of the VDCCs. However, further
experiments need to be done to identify the precise mechanisms.

4.3.2   The origins of EP3-expressing GABAergic inputs to PNCs
My data indicates that presynaptic EP3 receptors suppress the release of the
neurotransmitter from the local GABAergic neurons projecting to the PVN. However, the
origin of these EP3 receptors-expressing GABAergic inputs remains to be identified. It has
been shown that the anterior perifornical area, which is in some cases considered as part of
the BNST, is one of the local GABAergic regions projecting to the PVN (Roland and
Sawchenko, 1993). Histological studies from two independent labs have shown that the
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anterior perifornical area highly expresses EP3 receptor mRNA and protein (Ek et al.,
2000b; Nakamura et al., 2000). Together, we speculate that the anterior perifornical area
might be one of the major origins for GABAergic inputs on the PVN in response to PGE2
application.

4.4   PGE2 contributes to the HPA axis activation via nonGABA mechanisms.
My data indicate that PGE2 activates the HPA axis via the EP3 receptor-mediated
suppression of GABAergic synaptic transmission. However, in parallel or in concert with
this mechanism, there likely to be other mechanisms through which PGE2 drives the HPA
axis. As discussed earlier, an EP receptor KO mice study indicated that besides EP3, EP1
receptor mediates PGE2 effects on the HPA axis (Matsuoka et al., 2003). The neuronal
mechanisms downstream of EP1 receptor activation remain unknown. Moreover, another
in vivo study has shown that indomethacin (PG synthesis inhibitor) abolished IL-1βinduced noradrenaline (NA) releases in the hypothalamus, indicating the role of PGE2 in
NA release during inflammation (Tsumori et al., 1998). Indeed, PVN PNCs receive dense
noradrenergic inputs from the nucleus of the solitary tract (NTS) in the brain stem
(Cunningham and Sawchenko, 1988; Pacák, 2000) that are critical for inflammationinduced activation of the HPA axis (Dunn, 1988; Terao et al., 1993). The NTS NA
adrenergic neurons are believed to receive visceral sensory information including
peripheral inflammatory signals to promote HPA axis rapid response to immediate
physiological challenge (Herman et al., 2003, 2016). These findings raise a possibility that
in parallel with GABA, PGE2 drives NAergic inputs onto PNCs for the activation of the
HPA axis. Interestingly, it has also been shown that pharmacological blockade of COX-1
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and COX-2 (PG synthesizing enzymes) decreased NA-induced activation of the HPA axis
(Bugajski, 1996; Bugajski et al., 2001), pointing to a roles of PGE2 downstream of NA,
and thus potential bidirectional interaction between PGE2 and NA signaling .

4.5   Psychological stress impairs PGE2-mediated suppression
of GABA release.
Our results demonstrated that both single and repeated restraint stress impaired
PGE2-induced suppression of the GABA release, suggesting that preceding psychological
stress may decrease the excitatory effect of the PGE2 on parvocellular neuroendocrine
cells. Somewhat surprisingly, however, we found that EP3 agonist still significantly
suppressed GABA release to a similar extent as in slices from naïve rats. This suggested
that EP receptors other than EP3 cancelled out the inhibitory effects of EP3 and that such
mechanisms were unmasked by psychological stress. Indeed, when we examined the
individual synaptic response to PGE2 following stress, we observed that the preceding
psychological stress increased the variability in the synaptic responses: that is, PGE2
caused depression (as effective as in the case of stress naïve slices) in some synapses
whereas it caused an opposite potentiation in other synapses (Figure 3-13). Thus, one
interpretation would be that after psychological stress EP receptors other than EP3 drove
PGE2-induced potentiation of the GABA release. EP2 and EP4 are coupled to G protein
stimulatory α subunit (Gsα) that activate adenylyl cyclase and facilitate neurotransmitter
release (Furuyashiki and Narumiya, 2011; Betke et al., 2012). It has been shown that EP4
mRNA is highly expressed in the PVN (Zhang and Rivest, 1999). Taken together, we
speculate that EP4 receptors might be involved in PGE2-mediated potentiation of the
GABA release.
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4.6   Conclusion and significance
This study investigated the synaptic mechanism by which PGE2 excites PVN PNCs
and ultimately the HPA axis. My data showed that, PGE2 attenuated the GABAergic
synaptic transmission onto PNCs: this indicated that disinhibition could be one mechanism
by which PGE2 increased the excitability of the PNCs. Further, in depth analysis of the
changes in PGE2-induced synaptic plasticity revealed a presynaptic locus of PGE2 action
where EP3 receptor activation suppressed the release of GABA from the presynaptic
terminals. I also found that psychological stress impaired PGE2-induced suppression of
GABAergic inputs onto PNCs. This is likely due to the recruitment of EP receptors other
than EP3 that potentiated GABA synapse, whereas EP3-mediated GABA release
suppression was insensitive to psychological stress.
In response to systemic inflammation, PGE2 is produced in the brain, exerts various
physiological and psychological actions one of which is activation of the HPA axis
(Furuyashiki and Narumiya, 2011). The results from this study provide one possible
mechanism by which PGE2 regulates HPA axis response. Importantly, activation of the
HPA axis and the releases of glucocorticoids play critical roles in controlling the
inflammatory response and thereby preventing overactive immune response such as septic
shock (Silverman et al., 2005). Thus, our findings may ultimately be helpful for future
research trying to unravel the mechanisms involved in life-threatening diseases such as
endotoxemia or sepsis.
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